Warfarin Use in Hemodialysis Patients With Atrial Fibrillation: A Systematic Review of Stroke and Bleeding Outcomes.

ABSTRACT:

Background

Given the lack of clear indications for the use of warfarin in the treatment of atrial fibrillation (AF) in patients on hemodialysis and the potential risks that accompany warfarin use in these patients, we systematically reviewed stroke and bleeding outcomes in hemodialysis patients treated with warfarin for AF.

Objective

To systematically review the stroke and bleeding outcomes associated with warfarin use in the hemodialysis population to treat AF.

Design

Systematic review.

Setting

All adult hemodialysis patients.

Patients

Patients on hemodialysis receiving warfarin for the management of AF.

Measurements

Any type of stroke and/or bleeding outcomes.

Methods

MEDLINE(R) In-Process & Other Non-Indexed Citations and MEDLINE(R) via

SUBMITTER: Tsai C 

PROVIDER: S-EPMC5652660 | biostudies-literature | 2017

REPOSITORIES: biostudies-literature